My Blog List

Thursday, 16 November 2017

Multiple Sclerosis (MS) Drugs Market Estimated to Grow Strongly by 2022

Description:

In this report, the global Multiple Sclerosis (MS) Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Multiple Sclerosis (MS) Drugs in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India


Global Multiple Sclerosis (MS) Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Bayer AG
Bayhill Therapeutics
Biogen Idec
Cinnagen
Daiichi Sankyo
Eli Lilly
Fast Forward Llc
Antisense Therapeutics
Apitope
Five Prime Therapeutics
Genmab
Artielle Immunotherapeutics
Genzyme
Glaxosmithkline
Gw Pharmaceuticals
Innate Immunotherapeutics


On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Copaxone (Glatiramer Acetate, Copolymer 1)
Novantrone (Mitoxantrone)
Gilenya (Fingolimod, Fty720)
Aubagio (Teriflunomide)
Tecfidera (Dimethyl Fumarate)
Firategrast (Sb683699, T-0047)
Siponimod (Baf312)
Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
RRMS
SPMS
PPMS
PRMS

Make an Enquiry Of report for Discount @ https://www.reporthive.com/enquiry.php?id=1149202&req_type=disc

Table of Content:

1 Multiple Sclerosis (MS) Drugs Market Overview1.1 Product Overview and Scope of Multiple Sclerosis (MS) Drugs
1.2 Multiple Sclerosis (MS) Drugs Segment by Type (Product Category)
1.2.1 Global Multiple Sclerosis (MS) Drugs Production and CAGR (%) Comparison by Type (Product Category)(2012–2022)
1.2.2 Global Multiple Sclerosis (MS) Drugs Production Market Share by Type (Product Category) in 2016
1.2.3 Copaxone (Glatiramer Acetate, Copolymer 1)
1.2.4 Novantrone (Mitoxantrone)
1.2.5 Gilenya (Fingolimod, Fty720)
1.2.6 Aubagio (Teriflunomide)
1.2.7 Tecfidera (Dimethyl Fumarate)
1.2.8 Firategrast (Sb683699, T-0047)
1.2.9 Siponimod (Baf312)
1.2.10 Others
1.3 Global Multiple Sclerosis (MS) Drugs Segment by Application
1.3.1 Multiple Sclerosis (MS) Drugs Consumption (Sales) Comparison by Application (2012–2022)
1.3.2 RRMS
1.3.3 SPMS
1.3.4 PPMS
1.3.5 PRMS
1.4 Global Multiple Sclerosis (MS) Drugs Market by Region (2012–2022)
1.4.1 Global Multiple Sclerosis (MS) Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012–2022)
1.4.2 North America Status and Prospect (2012–2022)
1.4.3 Europe Status and Prospect (2012–2022)
1.4.4 China Status and Prospect (2012–2022)
1.4.5 Japan Status and Prospect (2012–2022)
1.4.6 Southeast Asia Status and Prospect (2012–2022)
1.4.7 India Status and Prospect (2012–2022)
1.5 Global Market Size (Value) of Multiple Sclerosis (MS) Drugs (2012–2022)
1.5.1 Global Multiple Sclerosis (MS) Drugs Revenue Status and Outlook (2012–2022)
1.5.2 Global Multiple Sclerosis (MS) Drugs Capacity, Production Status and Outlook (2012–2022)

2 Global Multiple Sclerosis (MS) Drugs Market Competition by Manufacturers2.1 Global Multiple Sclerosis (MS) Drugs Capacity, Production and Share by Manufacturers (2012–2017)
2.1.1 Global Multiple Sclerosis (MS) Drugs Capacity and Share by Manufacturers (2012–2017)
2.1.2 Global Multiple Sclerosis (MS) Drugs Production and Share by Manufacturers (2012–2017)
2.2 Global Multiple Sclerosis (MS) Drugs Revenue and Share by Manufacturers (2012–2017)
2.3 Global Multiple Sclerosis (MS) Drugs Average Price by Manufacturers (2012–2017)
2.4 Manufacturers Multiple Sclerosis (MS) Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Multiple Sclerosis (MS) Drugs Market Competitive Situation and Trends
2.5.1 Multiple Sclerosis (MS) Drugs Market Concentration Rate
2.5.2 Multiple Sclerosis (MS) Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
Read Full Table of Contents

About Report Hive Research

We are a leading repository of market research reports and solutions catering to industries like Comm & Technology, Energy & Power, Food And Beverages, Automotive & Transportation, Healthcare & Life Science etc. This large collection of reports assists organizations in decision-making on aspects such as market entry strategies, market sizing, market share analysis, competitive analysis, product portfolio analysis and opportunity analysis among others. We also assist in determining the best suited and targeted report from our large repository of global reports, company-specific reports and country-level reports.

Contact Us

Mike Ross
Marketing Manager
mike.ross@reporthive.com
http://www.reporthive.com
Phone: +1 312–604–7084
Sainath Nagar, Vadgaon Sheri,
Pune, Maharashtra 411014,
India